Does hyperandrogenic statute in the polycystic ovary syndrome constitute an obstacle to the success of in vitro fertilization?

被引:5
|
作者
Gaddas, M. [1 ]
Chaouache, N. [1 ]
Ajina, M. [2 ]
Tabka, Z. [1 ]
Ajina, M. Zaouali [1 ]
机构
[1] Fac Med Ibn el Jazzar, Lab Physiol & Explorat Fonct, Ave Mohamed Karoui, Sousse 4000, Tunisia
[2] CHU Farhat Hached, Unite Med Reprod, Ave Ibn el Jazzar, Sousse 4000, Tunisia
来源
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2016年 / 45卷 / 09期
关键词
Hyperandrogenism; IVF; Polycystic ovarian; syndrome; SYNDROME PCOS; ANDROGEN RECEPTORS; INSULIN-RESISTANCE; DOWN-REGULATION; WOMEN; TESTOSTERONE; CYCLES; CELL; STIMULATION; APOPTOSIS;
D O I
10.1016/j.jgyn.2016.08.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. The aim of this study was to evaluate the impact of initial androgenic statute of women with polycystic ovary syndrome (SOPK) on the expected results of in vitro fertilization (FIV). Materials and methods. It is about an exploratory study carried out in 61 unfertile SOPK patients, having profited all from a cycle of FIV/ICSI (intracytoplasmic sperm injection). We have divided our population in two groups according to their hormonal androgenic statute: groups with hyperandrogenism and without hyperandrogenism. We proceeded to note the anthropometric and hormonal parameters as well as results of FIV for each of the two groups. Results. SOPK patients with hyperandrogenism are more obese than their counterparts. Also, they have more oocytes collected after ovarian induction. In addition, we did not reveal any significant differences between our two study groups concerning parameters defining FIV response. Conclusion. Our findings suggest that hyperandrogenism statute in SOPK infertile women does not seem to compromise the results of FIV. On the contrary, it would make it possible to optimize the chances to puncture more significant number of oocytes. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [21] A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles
    Kim, Yong Jin
    Ku, Seung-Yup
    Jee, Byung Chul
    Suh, Chang Suk
    Kim, Seok Hyun
    Choi, Young Min
    Kim, Jung Gu
    Moon, Shin Yong
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 282 (02) : 199 - 205
  • [22] Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome
    Abruzzese, Giselle A.
    Gamez, Juan
    Belli, Susana H.
    Levalle, Oscar A.
    Mormandi, Eduardo
    Otero, Patricia
    Graffigna, Mabel N.
    Cerrone, Gloria E.
    Motta, Alicia B.
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (12) : 1057 - 1061
  • [23] The impact of polycystic ovary syndrome on placental histopathology patterns in in-vitro fertilization singleton live births
    Hochberg, Alyssa
    Mills, Ginevra
    Volodarsky-Perel, Alexander
    Nu, Tuyet Nhung Ton
    Machado-Gedeon, Alexandre
    Cui, Yiming
    Shaul, Jonathan
    Dahan, Michael H.
    PLACENTA, 2023, 139 : 12 - 18
  • [24] Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition
    Sprung, Victoria S.
    Jones, Helen
    Pugh, Christopher J. A.
    Aziz, Nabil F.
    Daousi, Christina
    Kemp, Graham J.
    Green, Daniel J.
    Cable, N. Timothy
    Cuthbertson, Daniel J.
    CLINICAL SCIENCE, 2014, 126 (1-2) : 67 - 74
  • [25] Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome
    Yang, Zuwei
    Zhou, Wenzhong
    Zhou, Chengliang
    Zhou, Yuzhong
    Liu, Xinmei
    Ding, Guolian
    Hu, Yulian
    Pan, Jiexue
    Sheng, Jianzhong
    Jin, Li
    Huang, Hefeng
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 206
  • [26] Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization
    Niu, Zhihong
    Ye, Yao
    Xia, Lan
    Feng, Yun
    Zhang, Aijun
    CYTOKINE, 2017, 91 : 180 - 186
  • [27] Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome
    Peng, Cuiying
    Guo, Zifen
    Long, Xingyu
    Lu, Guangxiu
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2012, 29 (07) : 603 - 607
  • [28] Effect of GnRHR polymorphisms on in vitro fertilization and embryo transfer in patients with polycystic ovary syndrome
    Chen, Wei-Yan
    Du, Yan-Qiu
    Guan, Xia
    Zhang, Hong-Yun
    Liu, Ting
    JOURNAL OF HUMAN GENETICS, 2017, 62 (12) : 1065 - 1071
  • [29] In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome
    Child, TJ
    Abdul-Jalil, AK
    Gulekli, B
    Tan, SL
    FERTILITY AND STERILITY, 2001, 76 (05) : 936 - 942
  • [30] Effect of comprehensive nursing intervention on the outcomes of in vitro fertilization in patients with polycystic ovary syndrome: A randomized controlled study
    Zhang, Lin
    Yin, Cao-Qing
    Sun, Shi-Jie
    Teng, Xue-Qin
    Li, Dong-Yan
    Sun, Jie
    Cui, Yuan-Yong
    MEDICINE, 2023, 102 (40) : E35489